|
|
Biotechnology is having an increasingly important impact on a number of sectors and disciplines. OECD has been working on biotechnology-related topics for over 25 years. These include scientific, industrial, health and agricultural applications. It also has a strong record on safety issues in biotechnology.
What's new
|
18-Nov-2009
This new book reviews the use of pharmacogenetics across all stages of the health innovation cycle from research through to uptake by doctors and patients. It focuses on how to optimise use of pharmacogenetics to deliver effective innovations for public health, and design policies that enhance their economic and social benefits.
|
|
12-Nov-2009
The recently adopted OECD Recommendation provides guidance on the establishment, management, governance, operation, access, use and discontinuation of HBGRDs. It has been developed to aid policymakers and practitioners who are establishing new HBGRDs, although many of the principles and best practices can also be usefully applied to HBGRDs already in existence.
|
|
from 23-Jul-2009 to 24-Jul-2009
Some of the topics dicussed at this workshop held on Montreal, Canada were: existing sector, national, or international approaches for assessment of sustainability of bio-based products, such as bio-based chemicals, bio-based plastics, enzymes, bio-based materials, and biofuels.
|
|
from 09-Jul-2009 to 10-Jul-2009
Synthetic biology is a transformative set of technologies which offer great opportunities for the construction of bioengineered parts, devices and microorganisms. However, achieving the rewards offered by synthetic biology will require addressing a range of social, economic, ethical, and legal issues as well as overcoming scientific and technical challenges. Given the enormous promise of synthetic biology, it is critical to develop a framework and to engage the public in an informed dialogue.
|
|
30-Jul-2009
These indicators bring together the latest available economic and activity data on biotechnology and innovation, collected by OECD member and non-member countries.
|
|
08-Jun-2009
Biotechnology has the power to improve human health, address environmental challenges, and change the way the world does business. A new OECD report, The Bioeconomy to 2030: Designing a Policy Agenda, examines the role of biotechnology in the global economy over the next two decades and outlines policies that could maximize its benefits.
|
|
25-May-2009
This new edition brings together the latest available economic and activity data on biotechnology and innovation for 22 OECD members and four non-member countries. It builds on the extensive work of the OECD and national experts to improve the comparability of biotechnology statistics.
|
|
20-Mar-2009
This document focuses on efforts in the United States to develop metrics to support sound decision choices by industry and consumers in the selection and use of biobased products. Public policy initiatives have been important in spurring the movement toward increased use of biobased products in the effort to lighten the US environmental footprint and enhance its energy security. This has included developing metrics based on sound science that also provide useful information to inform consumer selections of biobased products.
|
See more news and events…
Top of page
|
|
A free and easy way to receive the latest news releases and media alerts
